Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study-Reference-Cited by-同舟云学术

Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study

Published:2023-05-01 Issue:4 Volume:307 Page:
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Ragusi Max A. A.^ORCID,van der Velden Bas H. M.,Meeuwis Carla^ORCID,Tetteroo Eric,Coerkamp Emile G.^ORCID,van Nijnatten Thiemo J. A.^ORCID,Jansen Frits H.,Wolters-van der Ben Elian J. M.^ORCID,Jongen Lisa,van Raamt Fleur,Dorrius Monique D.,Verloop Janneke,Viergever Max A.,Pijnappel Ruud M.,Elias Sjoerd G.^ORCID,Gilhuijs Kenneth G. A.

Funder

Dutch Cancer Society

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.221922

Reference34 articles.

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

2. Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study

3. Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA